UNSPSC 51294414: Vilazodone

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S239O2OOV3. European Medicines Agency schedules Vilazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32166. Vilazodone generally arises in the molecular formula C26H27N5O2. The term VILAZODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 1, 2001, list 45.) Most nations schedule vilazodone under HS 29349990 and SITC 51579.

As of Q4 2014, VILAZODONE remains the US FDA Preferred Term for this commodity. Vilazodone bears US NLM identifiers UMLS ID C1530072 and NCI Concept Code C90716. SMILES: C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.

UNSPSC 51294414 Vilazodone, a Commodity code, reflects pharmaceutical procurement tagged in state and local opportunities, though the recent solicitation activity under this code shows a significant mismatch between the nominal scope and actual buying patterns. Vilazodone is a pharmaceutical antidepressant, but the only recent state-local opportunity associated with this code is Seminole County, Florida's procurement of naloxone (an opioid antagonist) and drug deactivation systems—a public health emergency-response product unrelated to antidepressant treatment. State and local governments buying under pharmaceutical commodity codes typically source through group purchasing organizations, cooperative agreements, or direct pharmacy benefit manager contracts rather than competitive bidding; the naloxone and deactivation-systems procurement suggests either miscoding of the opportunity or minimal recent activity aligned with vilazodone's actual therapeutic class. The issuing body in the recent record is a single county health department operating under a standard IFB process with E-Verify and drug-free workplace compliance requirements.

The geographic data point to Florida as the location of the one recent opportunity on record. Seminole County posted IFB 60459723LAS on June 30, 2026, seeking annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems with a response deadline of July 26, 2026, at 2:00 pm, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure offers a two-year initial term with one-year renewal options, and vendors must assume all shipping and delivery costs. Given the absence of corroborating vilazodone-specific solicitations and the mismatch between the code name and the naloxone procurement, this code shows little recent relevant activity in state and local procurement markets; firms should verify coding accuracy before dedicating pursuit resources.